Helius Medical Technologies Inc - Ordinary Shares - Class A
HSDT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$122.03M
Close$
$-2.15
206.8% downside
Current Fair Value
206.8% downsideOvervalued by 206.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $122.03 Million |
|---|---|
| Enterprise Value | $118.38 Million |
| Earnings per Share | $-1.85 |
| Beta | 1.12 |
| Outstanding Shares | 78,254,877 |
Return
| Return on Equity | -94.95% |
|---|---|
| Return on Assets | -89.33% |
| Return on Invested Capital | -147.91% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | -0.03 |
| Price to Sales | - |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | 9.81 |
| Enterprise Value to EBIT | -0.46 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.07
Consensus analyst estimateRevenue Estimate
$2.90 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$2.85 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 17.70% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 20.15% |
|---|---|
| Total Invested | $933▼ 100.00% |
| Investors Holding | 2▼ 43.00% |
About Helius Medical Technologies Inc
19 employees
CEO: Philippe Deschamps
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. ...